High free testosterone index increases lung function in adult males
Article Sidebar
Main Article Content
Abstract
Increasing age and decreased testosterone concentrations in males influence muscle strength and muscle mass, particularly in skeletal muscle. There have been few studies on decreased lung function resulting from reduced mass and strength of respiratory muscles. The aim of the present study was to investigate the existence of an association between free testosterone index (FTI) and lung function in males aged between 40 and 80 years.
Methods
This cross-sectional study involved 167 males aged between 40 and 80 years in Cilandak subdistrict, South Jakarta. Total serum testosterone and sex hormone-binding globulin (SHBG) concentrations were determined by electrochemiluminescence immunoassay (ECLIA) using Roche Elecsys Reagent Kit Cat 11776061 and Elecsys 2010 reagent (Cobas e601), respectively FTI was calculated using the formula free testosterone/SHBG x 100%. Forced expiratory volume in 1 second (VEP1) was assessed by means of an AS 500 spirometer.
Results
Mean age of the subjects was 53.32 ± 8.26 years, mean total serum testosterone concentration was 532.59 ± 206.92 ng/dL, mean SHBG concentration 41.26 ± 21.14 nmol/L, mean FTI 48.22 ± 14.34 %, and mean VEP1 was 1.63 ± 0.54 L. There was a significant association between both SHBG and FTI on the one hand and VEP1 on the other, with Pearson correlation coefficients of -0.199 (p=0.010) and 0.271 (p=0.000), respectively. Linear multiple regression analysis indicated that FTI was the most influential variable on lung function (VEP1), higher FTI values indicating higher VEP1 (â=0.008: p=0.004).
Conclusion
In males aged 40-80 years, higher FTI values indicate better lung function as determined by means of VEP1.
Article Details
The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.
References
Kementerian Kesehatan R.I. Menuju tua: sehat mandiri dan produktif. Panduan Peringatan Hari Kesehatan Sedunia, 7 April 2012. Available at: http://promkes.depkes.go.id/download/panduan _HKS_2012.pdf. Access April 22,2012.
Cunningham GR, Matsumoto AM, Swerdloff R. Low testosterone and men. Healthy J Clin Endocrinol Metab 2004;89:2-23.
Morales A, Buvat J, Googren LJ, Guay AT, Kaufman JM. Endocrine aspects of sexual dysfunction in men. J Sexual Med 2004;4:69-81.
Howe CL. Hypogonadism: evaluation and management in the older male. Arizona Geriatr J 2008;13:18-9.
Friedrich N, Volzke H, Rosskopf D, Stevelling A, Krebs A, Nauck M, et al. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl 2008;29:610-7.
Kaufman JM, Vermeulen A. The Decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833–76. doi: 10.1210/er.2004-0013.
Laghi F. Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003;168: 10-48.
Katznelson L, Robinson MW, Coyle CL, Lee H, Farrel CE. Effect of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. Eur J Endocrinol 2006;155:867-75.
Aranyo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Steroids and all cause and cause-specific mortality in men. Arch Intern Med 2007;167:1252-60.
Van Vliet M, Spruit MA, Varleden G, Kasran A, Van Herck E, Pitta F, et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1105-11.
Svartberg J, Schirmer H, Medbo A, Melbye H, Aasebo U. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone: the Tromso study. Eur J Epidemiol 2007;22:107–12.
Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M, Metter EJ. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002;283:E284-E94.
Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007;116:2694–701.
Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008;93:68–75.
Isodori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol 2005;63:280-93.
Witter GA, Chapman IM, Haren MT, Mackuitosh S, Coates P. Oral testosterone supplementation increase muscle and decrease fat mass in healthy elderly with low-normal gonad status. J Gerontol A Biol Sci Med Sci 2003;58:618-25.
Cruetzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;22:S76-80.
Gupta B, Kant S, Pant N. Chronic obstructive pulmonary disease: beyond respiratory system. Internet J Pulm Med 2008;10:4-14.
Rhoden EL, Morgentaler A. Risk of testosterone-replacement therapy and recommendations for monitoring. N Eng J Med 2004;350:482-92.
Cosabury R, Shalender B, Cosentino L, Porszasz J, Somfray A. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:870-8.
Morley JE, Patrick P, Perry HM. Evaluation of assays available to measure free testosterone. Metabolism 2002;51:554–9.